Radiopharm Theranostics Limited - American Depositary Shares (RADX) Institutional Ownership $4.15 -0.03 (-0.72%) As of 05/16/2025 03:59 PM Eastern Add Share Share Ownership Stock AnalysisAnalyst ForecastsChartOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Radiopharm Theranostics Limited - American Depositary Shares (NASDAQ:RADX)Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1 Get RADX Insider Trade Alerts Want to know when executives and insiders are buying or selling Radiopharm Theranostics Limited - American Depositary Shares stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Radiopharm Theranostics Limited - American Depositary Shares Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025 Affinity Asset Advisors LLC64,600$311K0.0%-58.6%0.861% (Data available from 1/1/2016 forward) RADX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RADX shares? During the previous two years, the following institutional investors and hedge funds held shares of Radiopharm Theranostics Limited - American Depositary Shares shares: Affinity Asset Advisors LLC ($311K).Learn more on RADX's institutional investors. Which Radiopharm Theranostics Limited - American Depositary Shares major shareholders have been selling company stock? The following institutional investors have sold Radiopharm Theranostics Limited - American Depositary Shares stock in the last 24 months: Affinity Asset Advisors LLC ($91.57K). How much institutional selling is happening at Radiopharm Theranostics Limited - American Depositary Shares? Institutional investors have sold a total of 91,571 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. This page (NASDAQ:RADX) was last updated on 5/17/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Radiopharm Theranostics Limited - American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Radiopharm Theranostics Limited - American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
